Email
Mot de passe
Pour plus de facilité, laissez cette case cochée. Sur les appareils partagés, nous vous conseillons de vous déconnecter d'Euroquity à la fin de votre utilisation
Email

Vous allez recevoir un email pour créer un nouveau mot de passe

Localisation

Choisissez votre pays

et votre langue

Bonjour ,

Bienvenue sur votre profil personnel. Votre carte de visite professionnelle présente votre activité principale. Elle sera visible sur EuroQuity.

% complété

%

medal 4
Ce profil est validé par 4 label.

Company

Ad Scientiam

Ad Scientiam_logo
8
EQ SCORE

L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.

PARIS, Île-de-France, France

Send a message

Anglais

Ad Scientiam

Anglais

Ad Scientiam develops software medical applications for patient monitoring in real life, collecting real-world data through digital tests, used to improve patient care and research

Founded in 2013, Ad Scientiam (ADS) is a company specialized in mHealth (mobile health) and real world medical data analysis, incubated at the Brain & Spine Institute (la Pitié-Salpêtrière Hospital, Paris). ADS is developing clinically-validated software medical...

See more

Ad Scientiam develops software medical applications for patient monitoring in real life, collecting real-world data through digital tests, used to improve patient care and research

Founded in 2013, Ad Scientiam (ADS) is a company specialized in mHealth (mobile health) and real world medical data analysis, incubated at the Brain & Spine Institute (la Pitié-Salpêtrière Hospital, Paris). ADS is developing clinically-validated software medical applications, each specific to a chronic disease, where patients assess the evolution of their disease, in their home environment, taking regular tests on their:

- MSCopilot (“MSC”)is the first Solution launched by ADS.It is the result of 2.5 years of R&D in partnership with ROCHE France. MSC received its Class 1 CE mark (October 2017) and is distributed in France, since November 2017.
- ADS has a pipeline of 7 solutions(rheumatoid arthritis, depression, Parkinson’s…). The experience built from MSC will allow ADS to accelerate its development and distribution cycle and support its extension to the U.S.

ADS will develop its activities in Europe and in the U.S.In 2018, ADS wants to occupy a leading position on Multiple Sclerosis assessment with MSCopilot
 

Team member(s)

Your request has been sent
Join this organization
Your request has been sent

Our network

Your request has been sent
Join this network
Your message has been sent

Certifications

Adhérent Medicen
20 Entities
InvestNet
Investnet is the certification of innovative companies supported by Bpifrance , with a majority of start-ups in technology profile .
1990 Entities
Seal of Excellence
The Seal of Excellence is a quality label awarded to project proposals submitted to Horizon 2020 which succeeded a highly competitive evaluation process by independent experts, but did not received funding due to budget limits. This quality label is a guarantee for investors to find high standard project proposals from European SMEs with growth potential.
1145 Entities

Communities

Bpifrance
ADVENTURE, IT'S FRANCE! Dynamizing and making the French economy more competitive is the role of Bpifrance Entrepreneurs, welcome!
2124 Members